Surreptitious TB Infections with Recently Identified DM People: A Cross- Sectional Study

Author(s): Tanniru Sireesha, Syed Asha*, Jojula Malathi.

Journal Name: Infectious Disorders - Drug Targets
(Formerly Current Drug Targets - Infectious Disorders)

Volume 19 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Tuberculosis (TB) among Diabetes Mellitus (DM) population is more expected to fail treatment of TB due to smear-negative TB.

Objective: We sought to compare and evaluate different methods to study the frequency of TB infections among DM patients.

Methods: Blood, sputum and urine samples were collected from 500 newly identified diabetic patients from different diabetic clinics in Warangal districts. Smear microscopy, Culture and Line Probe Assay by Polymerase Chain Reaction (LPA PCR) were used for identification of tuberculosis.

Results: Based on the chest X-Ray of 200 diabetic patients, suspected with pulmonary infections, 113 were males, 85 were females and 2 were children. All 200 patients were tested for tuberculosis infections, 55 were confirmed based on chest X-ray lesions. Off 55 patients, 30 were positive and 25 were negative for AFB microscopy, but were shown positive for chest X-ray. 22 were reported to be culture positive on solid media and identified as Mycobacterium tuberculosis based on morphology and biochemical methods. 36 samples were identified to be positive for LED, FM microscopy and LPA. Off 36 positive samples, 2 were MDR-TB and 34 were MTB based on LPA PCR method. Off 25 smear negative samples, 2 were identified as culture positive and confirmed to be MTB by morphological, biochemical tests.

Conclusion: Smear Negative Microscopy plays a vital role in the spread of tuberculosis infection among diabetic patients. Along with the smear microscopy, there is a need to rely on other methods for rapid identification and diagnosis of tuberculosis among the diabetic patients to control the spread of infection in the community and household contacts.

Keywords: Culture, DM-TB co-infections, LPA, Molecular Detection, Smear Negative Microscopy, Smear positive.

[1]
Dahiru, T.; Jibo, A.; Hassan, A.A.; Mande, A.T. Prevalence of diabetes in a semi-urban community in Northern Nigeria. Niger. J. Med., 2008, 17(4), 414-416.
[2]
Dooley, K.E.; Chaisson, R.E. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect. Dis., 2009, 9(12), 737-746.
[3]
Elorriaga, G.; Pineda, D.R. Type 2 Diabetes Mellitus as a Risk Factor for Tuberculosis. Mycobact. Dis., 2014, •••, 2161-1068.
[4]
Tuomilehto, J. The emerging global epidemic of type 1 diabetes. Curr. Diab. Rep., 2013, 13(6), 795-804.
[5]
World Health Organization. 2006.Diabetes fact sheet No. 312. Available: www. who.int/mediacentre/factsheets/fs312/ en/index.html
[6]
WHO The World Health Organization monitors the global tuberculosis epidemic and evaluates surveillance, planning and financial data in support of national TB control programmes, 2006, 1-3.
[7]
Anil, K.A.; Ginisha, G.; Priyesh, M.; Anju, A. A study of the patients suffering from tuberculosis and tuberculosis-diabetes comorbidity in Revised National Tuberculosis Control Program Centers of Northern Madhya Pradesh India 2017, 21, 570-576.
[8]
Siddiqi, K.; Lambert, M.L.; Walley, J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect. Dis., 2003, 3(5), 288-296.
[9]
Rieder, H.L.; Arnadottir, T.; Tardencilla Gutierrez, A.A.; Kasalika, A.C.; Salaniponi, F.L.M.; Ba, F.; Diop, A.H.; Anagonou, S.; Gninafon, M.; Ringdal, T.; Trébucq, A.; Enarson, D.A. Evaluation of a standardized recording tool for sputum smear microscopy for acid-fast bacilli under routine conditions in low income countries. Int. J. Tuberc. Lung Dis., 1997, 1(4), 339-345.
[10]
Kent, P.T.; Kubica, G.P. Public health mycobacteriology. A guide for the level III laboratory., 1985.
[11]
Davis, J.L.; Cattamanchi, A.; Cuevas, L.E.; Hopewell, P.C.; Steingart, K.R. Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis. Lancet Infect. Dis., 2013, 13(2), 147-154.
[12]
Steingart, K.R.; Henry, M.; Ng, V.; Hopewell, P.C.; Ramsay, A.; Cunningham, J.; Urbanczik, R.; Perkins, M.; Aziz, M.A.; Pai, M. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis., 2006, 6(9), 570-581.
[13]
Enarson, D.A.; Rieder, H.L.; Arnadottir, T.; Trébucq, A. Management of tuberculosis: a guide for low income countries., 2000.
[14]
Ramarokoto, H.; Rasolonavalona, T.; Ratsimba, L.; Andrianasolo, D.; Ratsitorahina, M.; Rasolofo Razanamparany, V. Evaluation of a rapid culture method on liquid Bio FM (BIO-RAD) medium for the isolation of mycobacteria. Int. J. Tuberc. Lung Dis., 2007, 11(8), 898-903.
[15]
Ben, J.M.; Wendy, B.; Katrien, P.; Hesseling, A.C.; Nulda, B.; Elizabeth, W. Use of Light-Emitting Diode Fluorescence Microscopy to Detect Acid-Fast Bacilli in Sputum Clinical Infectious Diseases., 2008, 2, 203-207.
[16]
Adler, H.; Sraub, C.; Frei, R. Comparison of BacT/ALERT 3D, Lowenstein-Jensen medium and Middlebrook 7H10/7H11 biplate for recovering mycobacteria from clinical specimens Eur Clin. Microbiol. Infect. Dis, 2005, 499-500.
[17]
Palomino, J.C. Leão, S.C.; Ritacco, V. Tuberculosis (Edinb.), 2007.
[18]
Amelia, B. Manual de Procedimientos. Clasificación fenotípica de las micobacterias; Dirección de Laboratorio y Control Técnico, 2007.
[19]
Organización, P.; de la Salud, D.L. Normas y Guía Técnica., 2008.
[20]
Steingart, K.R.; Schiller, I.; Horne, D.J.; Pai, M.; Boehme, C.C.; Dendukuri, N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev., 2014, 1(1)CD009593
[21]
Lee, K.S.; Song, K.S.; Lim, T.H.; Kim, P.N.; Kim, I.Y.; Lee, B.H. Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans. AJR Am. J. Roentgenol., 1993, 160(4), 753-758.
[22]
Kanchana, M.V.; Cheke, D.; Natyshak, I.; Connor, B.; Warner, A.; Martin, T. Evaluation of the BACTEC MGIT 960 system for the recovery of mycobacteria. Diagn. Microbiol. Infect. Dis., 2000, 37(1), 31-36.
[23]
Greco, S.; Girardi, E.; Navarra, A.; Saltini, C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax, 2006, 61(9), 783-790.
[24]
Foundation for innovative new diagnostics 2012.
[25]
Soundararajan, R.; Kavita, P.V.; Govindarajan, S.; Palanivel, C.; Krishna, C.P. Prevalence of Diabetes Mellitus among Tuberculosis Patients in Urban Puducherry, 2014, 6, 30-34.
[26]
Isik, A.; Firat, D.; Yilmaz, I.; Peker, K.; Idiz, O.; Yilmaz, B. survey of current approaches to thyroid nodules and thyroid operations ijsu, 2018, 54, 100-104.
[27]
Isik, A.; Firat, D.; Peker, K.; Inal, A.; Yilmaz, I.; Celebi, F. Breast Skin Necrosis After Methylene Blue Dye İnjection: Breast İmage. Sakaya Med, 2018, 8(1), 153-156.
[28]
Bashar, M.; Alcabes, P.; Rom, W.N.; Condos, R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service,1987 to 1997 2001, 120, 1514-1519.
[29]
Longo, F. Harrison’s Principles of Internal Medicine, 18th ed; , 2012, p. 165.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 2
Year: 2019
Page: [185 - 192]
Pages: 8
DOI: 10.2174/1871526518666181011152914
Price: $58

Article Metrics

PDF: 24
HTML: 3
EPUB: 1
PRC: 1